NEW YORK (GenomeWeb) – Arrayit today reported a 15 percent spike in first quarter sales driven by sales of microarray instruments.

Total revenues for the three months ended March 31 were $1.1 million up from $942,916 in the first quarter of 2013.

On an earnings call President Mark Schena attributed the growth to increased customer demand for the Sunnyvale, Calif.-based company's microarray products. During the quarter, Arrayit shipped three NanoPrint microarray printers, five SpotBot microarray printers, and a Colorimetric microarray platform, Schena said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.